Dr. Reddy's Laboratories Ltd Common Stock vs Stellantis N.V. Common Shares — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Stellantis N.V. Common Shares trades at $4.29 (market cap $16.51B). The key difference: Stellantis N.V. Common Shares is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Stellantis N.V. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| RDY | STLA | |
|---|---|---|
Market Cap | $10.78B | $16.51B |
Volume | 2,724,343 | 28,274,156 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.38 | $12.12 |
52-Week Low | $11.38 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $36.19B |
Dividend Yield | 0.65% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →